Abstract:Abstract Funding Acknowledgements Type of funding sources: None. Background The calculation of LV ejection fraction (LVEF) by transthoracic echocardiography is pivotal in detecting cancer therapy–related cardiac dysfunction. Referrals for LVEF estimation pre- and post-chemotherapy occupy significant amount of resources of echocardiography laboratories and increase service deliverance. Novel handheld ultrasound devices (HUDs) can provide echocardiographic images at the point of care with diagnostic image quality. Recently, artificial intelligence (AI) technology enabled the development of algorithms for the real-time guidance of ultrasound probe to acquire optimal images of the heart and calculate LVEF automatically. Purpose To evaluate the feasibility and accuracy of LVEF calculation by oncology staff using an AI enabled HUD. Methods We studied 115 oncology patients referred for echocardiographic LVEF estimation. All patients were scanned by a cardiologist using standard echocardiography (SE) systems and biplane Simpson’s rule was used as reference standard. A brief training on echocardiography basics and use of HUD was provided to the oncology staff before the study. Then, each patient was scanned independently by a cardiologist, a senior oncologist, an oncology resident, and an oncology nurse using the AUTO-GUIDANCE and AUTO-GRADING AI applications of the HUD (Figure 1) to acquire apical 4-chamber and 2-chamber views of the heart. The LVEF was automatically calculated by the device autoEF algorithm. Method agreement was assessed using Pearson’s correlation and Bland-Altman analysis. The diagnostic accuracy for detection of impaired LVEF<50%, a commonly used cut-off point for deferring chemotherapy, was calculated. Results Diagnostic images acquisition was possible in 96% of cases by the cardiologist, in 94% of cases by the senior oncologist, in 93% by the junior oncologist and in 89% by the nurse. The correlation between autoEF and SE-EF (Figure 2A) was excellent for the cardiologist (r=0.90), good for the senior oncologist (r=0.79), excellent for the junior oncologist (r=0.82) and excellent for the nurse (r=0.84), p<0.001 for all. The Bland-Altman plots (Figure 2B) showed a small underestimation of LVEF by the HUD autoEF algorithm compared to SE-EF for all the operators. There was bias −2.1% for the cardiologist, bias −3.5% for the senior oncologist, bias −2.2% for the junior oncologist, and bias −2.3% for the nurse (p<0.001 for all). Detection of impaired LVEF by autoEF algorithm was feasible with sensitivity 95% and specificity 94% for the cardiologist; sensitivity 86% and specificity 93% for the senior oncologist; sensitivity 95% and specificity 91% for the junior oncologist; sensitivity 94% and specificity 87% for the nurse. Conclusions Calculation of automated LVEF by oncology staff was feasible using AI enabled HUD in a selected patient population. Detection of impaired LVEF was possible with good accuracy. These findings show clinical potential to improve the quality of care for oncology patients.

Artificial intelligence-enhanced risk stratification of cancer therapeutics-related cardiac dysfunction using electrocardiographic images

Artificial Intelligence-Enhanced Risk Stratification of Cancer Therapeutics-Related Cardiac Dysfunction Using Electrocardiographic Images

Artificial intelligence-enabled prediction of chemotherapy-induced cardiotoxicity from baseline electrocardiograms

Artificial Intelligence Applied to Electrocardiographic Images for Scalable Screening of Transthyretin Amyloid Cardiomyopathy

Clinical service evaluation of the feasibility and reproducibility of novel artificial intelligence based-echocardiographic quantification of global longitudinal strain and left ventricular ejection fraction in trastuzumab-treated patients

Artificial Intelligence Enabled Interpretation of ECG Images to Predict Hematopoietic Cell Transplantation Toxicity

Artificial intelligence-enhanced electrocardiography predicts 10-year risk of atherosclerotic cardiovascular disease

Prediction of cancer therapy related cardiac dysfunction by using a machine learning approach with cardiac magnetic resonance images

Tracking the pre-clinical progression of transthyretin amyloid cardiomyopathy using artificial intelligence-enabled electrocardiography and echocardiography

Predictive Value of Artificial Intelligence-Enabled Electrocardiography in Patients With Takotsubo Cardiomyopathy

Characterizing the progression of subclinical cardiac amyloidosis through artificial intelligence applied to electrocardiographic images and echocardiograms

Artificial intelligence-enabled electrocardiogram for mortality and cardiovascular risk estimation: a model development and validation study

Artificial Intelligence Enabled Prediction of Heart Failure Risk from Single-lead Electrocardiograms

Use of artificial intelligence for the automatic assessment of left ventricular ejection fraction by oncology staff in chemotherapy patients

Artificial intelligence-enhanced electrocardiography in cardiovascular disease management

Artificial Intelligence-Enhanced Electrocardiography Identifies Patients With Normal Ejection Fraction at Risk of Worse Outcomes

Dynamic risk stratification of worsening heart failure using a deep learning-enabled implanted ambulatory single-lead electrocardiogram

An interpretable AI-derived radiology signature to identify patients at risk of progression on the PACIFIC regimen for unresectable non-small cell lung cancer.

Predictors of mortality by an artificial intelligence enhanced electrocardiogram model for cardiac amyloidosis

AI-Defined Cardiac Anatomy Improves Risk Stratification of Hybrid Perfusion Imaging

Mortality Risk Stratification Utilizing Artificial Intelligence Electrocardiogram for Hyperkalemia in Cardiac Intensive Care Unit Patients